VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | CLL: the GREEN study

Véronique Leblond, MD, Hematology at Pitié Salpêtrière Hospital, Paris, France, explores the results of a subgroup analysis of the GREEN study (NCT01905943), evaluating obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter